drugset / Trial / NCT01390584

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

NCT01390584

Non-randomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, bleomycin sulfate, vinblastine, dacarbazine, cyclophosphamide, etoposide, procarbazine hydrochloride, vincristine sulfate, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x rays to kill cancer cells. Giving combination chemotherapy together with radiation therapy may kill more cancer cells. Comparing results of imaging procedures, such as PET scans and CT scans, done before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase II clinical trial studies how well chemotherapy based on PET/CT scan works in treating patients with stage I or stage II Hodgkin lymphoma.

Timeline

Start
2013-05-24
Primary completion
2015-04-09
Completion
2018-05-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown Intravenous
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Dacarbazine Small molecule Intravenous
Subject Doxorubicin Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Prednisone Other / unclassified Oral
Subject Vinblastine Small molecule Intravenous
Subject Vincristine Small molecule Intravenous
Subject procarbazine Small molecule Oral

Indications